These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31630073)

  • 1. Hemorrhagic complications during extracorporeal membrane oxygenation - The role of anticoagulation and platelets.
    Oude Lansink-Hartgring A; de Vries AJ; Droogh JM; van den Bergh WM
    J Crit Care; 2019 Dec; 54():239-243. PubMed ID: 31630073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Versus Therapeutic Anticoagulation in Patients on Extracorporeal Membrane Oxygenation: A Pilot Randomized Trial.
    Aubron C; McQuilten Z; Bailey M; Board J; Buhr H; Cartwright B; Dennis M; Hodgson C; Forrest P; McIlroy D; Murphy D; Murray L; Pellegrino V; Pilcher D; Sheldrake J; Tran H; Vallance S; Cooper DJ;
    Crit Care Med; 2019 Jul; 47(7):e563-e571. PubMed ID: 31033512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.
    Northrop MS; Sidonio RF; Phillips SE; Smith AH; Daphne HC; Pietsch JB; Bridges BC
    Pediatr Crit Care Med; 2015 Jan; 16(1):66-74. PubMed ID: 25319630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
    Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
    Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorrhagic complications in pediatric cardiac patients on extracorporeal membrane oxygenation: an analysis of the Extracorporeal Life Support Organization Registry.
    Werho DK; Pasquali SK; Yu S; Donohue J; Annich GM; Thiagarajan RR; Hirsch-Romano JC; Gaies MG;
    Pediatr Crit Care Med; 2015 Mar; 16(3):276-88. PubMed ID: 25651048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Clinical Impact of Reduced Coagulation Factor XII Activity in Patients Receiving Extracorporeal Membrane Oxygenation.
    Buchtele N; Schwameis M; Schellongowski P; Quehenberger P; Knöbl P; Traby L; Schmid M; Schoergenhofer C; Herkner H; Jilma B; Staudinger T
    Crit Care Med; 2021 Dec; 49(12):e1206-e1211. PubMed ID: 34259662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
    Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
    Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
    Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study.
    Descamps R; Moussa MD; Besnier E; Fischer MO; Preau S; Tamion F; Daubin C; Cousin N; Vincentelli A; Goutay J; Du Cheyron D
    Crit Care; 2021 Apr; 25(1):127. PubMed ID: 33810800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifiable Risk Factors and Mortality From Ischemic and Hemorrhagic Strokes in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation: Results From the Extracorporeal Life Support Organization Registry.
    Cho SM; Canner J; Chiarini G; Calligy K; Caturegli G; Rycus P; Barbaro RP; Tonna J; Lorusso R; Kilic A; Choi CW; Ziai W; Geocadin R; Whitman G
    Crit Care Med; 2020 Oct; 48(10):e897-e905. PubMed ID: 32931195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulations Studies Do Not Correlate With Each Other or With Hematologic Complications During Pediatric Extracorporeal Membrane Oxygenation.
    Deshpande SJ; Vitali S; Thiagarajan R; Brediger S; McManus M; Geva A
    Pediatr Crit Care Med; 2021 Jun; 22(6):542-552. PubMed ID: 33660700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of percutaneous dilatational tracheostomy in patients on extracorporeal lung support.
    Braune S; Kienast S; Hadem J; Wiesner O; Wichmann D; Nierhaus A; Simon M; Welte T; Kluge S
    Intensive Care Med; 2013 Oct; 39(10):1792-9. PubMed ID: 23892417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Side by Side Comparison of Outcomes and Complications With a Simple Versus Intensive Anticoagulation Monitoring Strategy in Pediatric Extracorporeal Life Support Patients.
    Yu JS; Barbaro RP; Granoski DA; Bauman ME; Massicotte MP; Lequier LL; Annich GM; Ryerson LM
    Pediatr Crit Care Med; 2017 Nov; 18(11):1055-1062. PubMed ID: 28922263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.
    Fitousis K; Klasek R; Mason PE; Masud F
    Perfusion; 2017 Apr; 32(3):238-244. PubMed ID: 27837164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.
    Liveris A; Bello RA; Friedmann P; Duffy MA; Manwani D; Killinger JS; Rodriquez D; Weinstein S
    Pediatr Crit Care Med; 2014 Feb; 15(2):e72-9. PubMed ID: 24335992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stratification of Bleeding Risk Using Thromboelastography in Children on Extracorporeal Membrane Oxygenation Support.
    Sleeper LA; Mulone M; Diallo F; Nasr VG; Thiagarajan RR; Emani S; Emani S
    Pediatr Crit Care Med; 2021 Mar; 22(3):241-250. PubMed ID: 33512982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding and Thrombotic Events During Extracorporeal Membrane Oxygenation for Postcardiotomy Shock.
    Melehy A; Ning Y; Kurlansky P; Kaku Y; Fried J; Hastie J; Ciolek A; Brodie D; Eisenberger AB; Sayer G; Uriel N; Takayama H; Naka Y; Takeda K
    Ann Thorac Surg; 2022 Jan; 113(1):131-137. PubMed ID: 33609547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk Factors for Cannula-Related Venous Thrombosis After Venovenous Extracorporeal Membrane Oxygenation in Adult Patients With Acute Respiratory Failure.
    Fisser C; Reichenbächer C; Müller T; Schneckenpointner R; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Lubnow M
    Crit Care Med; 2019 Apr; 47(4):e332-e339. PubMed ID: 30855325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.